Fabrinet Investing Cash Flow increased by 45.5% to -$13.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 90.0%, from -$137.05M to -$13.70M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 28.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$47.54M | -$6.24M | -$29.44M | -$52.33M | $23.37M | -$44.95M | -$48.87M | -$28.27M | -$53.08M | -$48.77M | -$16.76M | -$51.14M | -$71.99M | -$44.08M | -$137.05M | -$33.17M | -$80.96M | -$25.16M | -$13.70M |
| QoQ Change | — | +86.9% | -371.7% | -77.7% | +144.7% | -292.4% | -8.7% | +42.2% | -87.8% | +8.1% | +65.6% | -205.1% | -40.8% | +38.8% | -210.9% | +75.8% | -144.1% | +68.9% | +45.5% |
| YoY Change | — | — | — | — | +149.2% | -620.1% | -66.0% | +46.0% | -327.2% | -8.5% | +65.7% | -80.9% | -35.6% | +9.6% | -717.6% | +35.1% | -12.5% | +42.9% | +90.0% |